NPIPB8
geneOn this page
Summary
NPIPB8 (nuclear pore complex interacting protein family member B8, HGNC:37490) is a protein-coding gene on chromosome 16p11.2, encoding Nuclear pore complex-interacting protein family member B8 (E9PQR5).
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_001310136
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37490 |
| Approved symbol | NPIPB8 |
| Name | nuclear pore complex interacting protein family member B8 |
| Location | 16p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000255524 |
| Ensembl biotype | protein_coding |
| Entrez | 728734 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000526428, ENST00000529716, ENST00000683297
RefSeq mRNA: 2 — MANE Select: NM_001310136
NM_001310136, NM_001385922
CCDS: CCDS81963
Canonical transcript exons
ENST00000683297 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002145710 | 28651957 | 28652056 |
| ENSE00002154265 | 28656463 | 28656523 |
| ENSE00002179896 | 28648135 | 28648317 |
| ENSE00002183441 | 28656633 | 28656668 |
| ENSE00002198386 | 28652169 | 28652364 |
| ENSE00003916186 | 28638065 | 28638150 |
| ENSE00003921791 | 28658028 | 28658744 |
| ENSE00003922118 | 28638323 | 28638480 |
Expression profiles
Bgee: expression breadth ubiquitous, 127 present calls, max score 79.86.
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.86 | silver quality |
| left testis | UBERON:0004533 | 79.10 | gold quality |
| testis | UBERON:0000473 | 78.32 | gold quality |
| right testis | UBERON:0004534 | 78.21 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.76 | silver quality |
| stromal cell of endometrium | CL:0002255 | 65.50 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 64.61 | gold quality |
| cortical plate | UBERON:0005343 | 61.54 | gold quality |
| duodenum | UBERON:0002114 | 60.50 | gold quality |
| tonsil | UBERON:0002372 | 57.80 | gold quality |
| cerebellum | UBERON:0002037 | 55.02 | gold quality |
| cerebellar cortex | UBERON:0002129 | 54.86 | gold quality |
| granulocyte | CL:0000094 | 54.51 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 54.48 | gold quality |
| apex of heart | UBERON:0002098 | 54.44 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 53.47 | gold quality |
| right coronary artery | UBERON:0001625 | 53.11 | gold quality |
| left ovary | UBERON:0002119 | 53.00 | gold quality |
| right ovary | UBERON:0002118 | 52.97 | gold quality |
| skin of leg | UBERON:0001511 | 52.09 | gold quality |
| ovary | UBERON:0000992 | 51.94 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 51.82 | gold quality |
| tibial nerve | UBERON:0001323 | 51.36 | gold quality |
| zone of skin | UBERON:0000014 | 51.26 | gold quality |
| transverse colon | UBERON:0001157 | 51.25 | gold quality |
| colonic epithelium | UBERON:0000397 | 51.10 | silver quality |
| ectocervix | UBERON:0012249 | 50.85 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 50.55 | gold quality |
| uterine cervix | UBERON:0000002 | 50.54 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 50.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.02 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (19): NPIPB12 (ENSG00000169203), NPIPB3 (ENSG00000169246), NPIPA1 (ENSG00000183426), NPIPA5 (ENSG00000183793), NPIPA6 (ENSG00000183889), NPIPB4 (ENSG00000185864), NPIPB15 (ENSG00000196436), NPIPB9 (ENSG00000196993), NPIPB13 (ENSG00000198064), NPIPB6 (ENSG00000198156), NPIPA8 (ENSG00000214940), NPIPA7 (ENSG00000214967), NPIPA3 (ENSG00000224712), NPIPA9 (ENSG00000233024), NPIPB7 (ENSG00000233232), NPIPB2 (ENSG00000234719), NPIPB5 (ENSG00000243716), NPIPB11 (ENSG00000254206), NPIPA2 (ENSG00000254852)
Protein
Protein identifiers
Nuclear pore complex-interacting protein family member B8 — E9PQR5 (reviewed: E9PQR5)
All UniProt accessions (2): E9PQR5, H0YDQ7
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the NPIP family.
RefSeq proteins (2): NP_001297065, NP_001372851 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009443 | NPIP | Family |
| IPR054697 | NPIP_N | Domain |
Pfam: PF06409
UniProt features (6 total): compositionally biased region 3, region of interest 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-E9PQR5-F1 | 52.40 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 10 (showing top):
chr16p11, HES2_TARGET_GENES, IGLV5_37_TARGET_GENES, KMT2D_TARGET_GENES, LHX9_TARGET_GENES, LHX2_TARGET_GENES, DNMT3A_TARGET_GENES, HOEK_B_CELL_2011_2012_TIV_ADULT_1DY_UP, HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_UP, GENES_CORRELATED_WITH_RICTOR_DELETION
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
579 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NPIPB8 | OR10H5 | Q8NGA6 | 605 |
| NPIPB8 | C2orf74 | A8MZ97 | 529 |
| NPIPB8 | OR10H1 | Q9Y4A9 | 506 |
| NPIPB8 | EFCAB13 | Q8IY85 | 477 |
| NPIPB8 | H0YL38 | H0YL38 | 445 |
| NPIPB8 | ZNF280D | Q6N043 | 435 |
| NPIPB8 | MALRD1 | Q5VYJ5 | 430 |
| NPIPB8 | APOL4 | Q9BPW4 | 418 |
| NPIPB8 | RABEP2 | Q9H5N1 | 398 |
| NPIPB8 | SYS1 | Q8N2H4 | 397 |
| NPIPB8 | APOBR | Q0VD83 | 366 |
| NPIPB8 | CLN3 | Q13286 | 366 |
| NPIPB8 | HMG20A | Q9NP66 | 356 |
| NPIPB8 | DEXI | O95424 | 348 |
| NPIPB8 | MSANTD1 | Q6ZTZ1 | 320 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0B4J1W7, A0A7H0DN35, A4QN01, A6NHN6, A6NJ64, A8MQ11, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F5HGC2, F8W1W9, F8WFD2, O75200, O83374, P05913, P06486, P07396, P0C7Q2, P0CK47, P0CK48, P0DM63, P0DXC3, P15489, P16765, P16802, P20969, P36443, P38900, P47003, P68341, P68454, P68455, P87191, P92537, P92561, Q03418, Q32M92, Q4ZGE2
Diamond homologs: A0A0B4J1W7, A6NHN6, A6NJ64, A6NJU9, A8MRT5, C9JG80, E5RHQ5, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F8W0I5, F8W1W9, F8WFD2, O75200, P0DM63, P0DXC3, Q92617, Q9UND3, O70490, Q08AH1, Q08AH3, Q3UNX5, Q53FZ2, Q5REV5, Q68CK6, Q6AYT9, Q6NUN0, Q6SKG1, Q8BGA8, Q8K0L3, Q91VA0, Q9BEA2, A0A179HJB8, A4YDT1, C0SPB0, P0C7M7, P39062, Q6P461
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1235 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:28651952:CCTA:C | acceptor_loss | 1.0000 |
| 16:28651954:TA:T | acceptor_loss | 1.0000 |
| 16:28651955:A:AC | acceptor_loss | 1.0000 |
| 16:28651956:GGT:G | acceptor_gain | 1.0000 |
| 16:28652052:GAAAG:G | donor_gain | 1.0000 |
| 16:28652053:AAAG:A | donor_loss | 1.0000 |
| 16:28652054:AAGG:A | donor_loss | 1.0000 |
| 16:28652055:AGGTA:A | donor_loss | 1.0000 |
| 16:28652056:GGTAT:G | donor_loss | 1.0000 |
| 16:28652057:G:A | donor_loss | 1.0000 |
| 16:28652058:T:A | donor_loss | 1.0000 |
| 16:28652365:G:GG | donor_gain | 1.0000 |
| 16:28656524:G:GG | donor_gain | 1.0000 |
| 16:28638478:AAGGT:A | donor_loss | 0.9900 |
| 16:28638479:AGG:A | donor_loss | 0.9900 |
| 16:28638482:T:A | donor_loss | 0.9900 |
| 16:28648240:GA:G | donor_gain | 0.9900 |
| 16:28648316:GT:G | donor_gain | 0.9900 |
| 16:28648318:G:GG | donor_gain | 0.9900 |
| 16:28651955:A:AG | acceptor_gain | 0.9900 |
| 16:28651956:G:GG | acceptor_gain | 0.9900 |
| 16:28651956:GGTGT:G | acceptor_gain | 0.9900 |
| 16:28652166:AAG:A | acceptor_gain | 0.9900 |
| 16:28652166:AAGG:A | acceptor_gain | 0.9900 |
| 16:28652167:A:G | acceptor_gain | 0.9900 |
| 16:28652362:ACA:A | donor_gain | 0.9900 |
| 16:28655334:A:AG | acceptor_gain | 0.9900 |
| 16:28656667:GG:G | donor_gain | 0.9900 |
| 16:28656668:GG:G | donor_gain | 0.9900 |
| 16:28656668:GGT:G | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000022197 (16:28652979 G>C), RS1000115233 (16:28652567 G>A), RS1000290041 (16:28636703 A>G), RS1000297066 (16:28640995 C>T), RS1000567276 (16:28641107 C>T), RS1001138221 (16:28644032 G>C), RS1001529869 (16:28640630 G>A), RS1001618007 (16:28640928 A>AT), RS1001647163 (16:28647826 G>A), RS1001717702 (16:28635912 C>A,T), RS1001799851 (16:28637869 A>C), RS1001909718 (16:28651755 A>C), RS1002343423 (16:28636171 T>A,C), RS1002509388 (16:28643698 T>C), RS1002640556 (16:28640210 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004131_83 | Inflammatory bowel disease | 2.000000e-12 |
| GCST004132_69 | Crohn’s disease | 3.000000e-10 |
| GCST005316_467 | Intelligence (MTAG) | 1.000000e-09 |
| GCST006269_378 | General cognitive ability | 1.000000e-10 |
| GCST006269_758 | General cognitive ability | 5.000000e-09 |
| GCST010133_15 | Lamb consumption | 3.000000e-08 |
| GCST010703_152 | Brain morphology (MOSTest) | 3.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004337 | intelligence |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB clinical annotations
3 annotations.
| Variant | Type | Level | Drugs | Phenotypes |
|---|---|---|---|---|
| rs28374453 | Metabolism/PK | 3 | tapentadol | |
| rs28374453 | Metabolism/PK | 3 | desmethylnaproxen | |
| rs28374453 | Metabolism/PK | 3 | acetaminophen |
PharmGKB variants
7 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs750155 | NPIPB8, SULT1A1 | 0.00 | 0 | ||
| rs1059491 | NPIPB8, SULT1A2 | 0.00 | 0 | ||
| rs1136703 | NPIPB8, SULT1A2 | 0.00 | 0 | ||
| rs1801030 | NPIPB8, SULT1A1, SULT1A2 | 0.00 | 0 | ||
| rs3760091 | NPIPB8, SULT1A1 | 0.00 | 0 | ||
| rs8049439 | ATXN2L, IL27, NPIPB8 | 0.00 | 0 | ||
| rs28374453 | NPIPB8, SULT1A1 | 3 | 0.00 | 3 | tapentadol;acetaminophen;desmethylnaproxen |
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-palmitoylglycerol | increases expression | 1 |
| abrine | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Ethanol | affects cotreatment, increases abundance, increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Gasoline | affects cotreatment, increases abundance, increases expression | 1 |
| Polycyclic Aromatic Hydrocarbons | increases expression, affects cotreatment, increases abundance | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Particulate Matter | affects cotreatment, increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.